METHYL 6-BROMO-5-METHYLPYRIDAZINE-3-CARBOXYLATE, 95%, 1g

1-(4-Chlorophenyl)imidazoline-2-thione, 98.0%, 1g

ethyl 2-diazo-3-oxobutanoate, 97%, 25g

1,3,5-Triazinane-2-thione, 95.0%, 500mg

3-(4-morpholinyl)-3-oxopropanoic acid, 95.0%, 5g

4-(Benzyloxy)-3,5-dimethoxybenzaldehyde, 95.0%, 5g

(4-Hydroxyphenyl)(2,4,6-trihydroxyphenyl)methanone, 98%, 1mg

1-Bromo-2-(dimethoxymethyl)benzene, 97%, 100g

tert-Butyl hexahydro-1H-pyrrolo[3,2-c]pyridine-5(6H)-carboxylate, 95.0%, 250mg

7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, 95.0%, 25g

Fmoc-D-Ser-OH, 95%, 1g

Benazepril hydrochloride, 99%, 100mg

E-Plan phase EPLPH 10x/0.25 objective. Working distance 6.61 mm